Abstract
To investigate lncRNAs acting as competing endogenous RNAs (ceRNAs) involved in oncogenesis and progression of HCC. Different expressed lncRNAs, microRNAs, and mRNAs (DElncRNAs, DEmiRNAs, DEmRNAs), downloaded from The Cancer Genome Atlas (TCGA) database, were identified by edgeR package. CeRNA network was constructed based on miRcode, TargetScan, and miRTarBase. Target DEmRNAs were annotated by KEGG pathway and GO analysis. Negatively correlated lncRNA-miRNA pairs were analyzed by Pearson correlation coefficient, simultaneously, overall survival (OS) were evaluated. The expression of these lncRNAs were examined in HCC cell lines and tissues through qRT-PCR. 1070 DElncRNAs, 147 DEmiRNAs and 1993 DEmRNAs were acquired. CeRNA network was successfully established, including 27 lncRNAs, 5 miRNAs, and 30 mRNAs significantly correlated with OS. The DEmRNAs were significantly enriched in “Cell Cycle” and “pathways in cancer”. Six lncRNAs and 2 miRNAs were negatively correlated. These lncRNAs were validated by qRT-PCR. These observations will provide a novel perspective to elucidate HCC pathogenesis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hepatocellular carcinoma (HCC) has the highest incidence among all subtypes of liver cancer [1]. In 2018, HCC ranked as the sixth most common cancer and the fourth leading cause of cancer related death.[2]. The main risk factors of HCC are infection by hepatitis B or C virus, cirrhosis, alcohol, and metabolic diseases [3,4,5]. However, the molecular mechanisms underlying HCC is unclear. Therefore, this study aimed to identify novel biomarkers and possible pathogenesis for HCC.
Accumulating evidence based on next-generation sequencing suggests that more than three-quarters of genes are non-coding RNAs, among which microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are more studied. LncRNAs are more than 200 nucleotides in length, and could be potential biomarkers and therapeutic targets for cancer by participating in transcriptional regulation and post-transcriptional regulation [6,7,8]. The competitive endogenous RNA (ceRNA) refers to the interaction between miRNA response elements (MREs) and lncRNAs to form a giant RNA network and regulate physiological and pathological processes [9]. Many studies have confirmed that in the ceRNA network, lncRNAs complementary to miRNA sequences regulate the encoded proteins through sponge miRNA [10,11,12,13].
The Cancer Genome Atlas (TCGA) is a public dataset based on clinicopathological data and high throughput sequencing results from huge number of patients with various types of cancer, and has been employed to understand molecular basis of cancer. At present, information from 10, 000 patients has been collected to provide convenience for cancer research. In present study, RNA expression profiles were downloaded from TCGA, and differentially expressed RNAs were identified. Next, CeRNA network was constructed to reveal the crosstalk of differentially expressed lncRNAs, differentially expressed miRNAs and differentially expressed mRNAs (DElncRNAs, DEmiRNAs, and DEmRNAs). Finally, quantitative RT-PCR was used to verify that these results are consistent with the results on our specimens. The ceRNAs in HCC will provide important clues on molecular mechanism of HCC.
Materials and methods
Data source
The RNA-Seq data of patients in TCGA-LIHC project were downloaded from TCGA data portal (https://portal.gdc.cancer.gov/, accessed February 7, 2019), as well as the corresponding clinical information (Cancer Genome Atlas Research, 2011). 14254 lncRNA ID and 19660 mRNA ID were annotated in the GENCODE annotation file in GTF format of 374 HCC tumor tissues and 50 adjacent normal liver tissues; 1881 miRNAs were also downloaded from TCGA.
Screening of differentially expressed lncRNAs/miRNAs/mRNAs
The edgeR package of the R platform was used for DElncRNAs/DEmiRNAs/DEmRNAs screening in comparison with expression levels between HCC tumor and adjacent normal liver tissues, with the thresholds of |log2FC|> 2.0 and adjusted P < 0.05.
CeRNA network construction
LncRNA-miRNA interactions were combined with DElncRNAs and DEmiRNAs according to miRcode database. Target mRNAs for DEmiRNAs were predicted using miRTarBase and TargetScan database, respectively. Then, the intersection of the target mRNAs predicted by two databases was considered as the final target mRNAs of DEmiRNAs. The ceRNA regulatory network visualization for the regulatory relationship between lncRNA-miRNA and miRNA-mRNA was conducted using Cytoscape.
Functional and pathway enrichment analysis of common mRNA
GO and KEGG analyses were applied for the functional annotation and pathway analysis, using the Database for Annotation Visualization and Integrated Discovery (DAVID; https://david.ncifcrf.gov/). Three GO categories [cellular component (CC), biological process (BP) and molecular function MF)] were detected. The mRNAs in the ceRNA network were analyzed in DAVID. The human genome was selected as the background parameter. P < 0.05 and a count ≥ 2 were set as the thresholds to indicate a statistically significant difference.
Survival analysis
The “survival” package in R software was used to plot the Kaplan–Meier curves of DElncRNAs, DEmiRNAs, and DEmRNAs of the ceRNA network, with P < 0.05.
Clinical significance Analysis
LncRNAs were analyzed with clinicopathological characteristics of HCC patients, including gender (male or female), age (over or under 60 years), risk factors (alcohol consumption, hepatitis B, hepatitis C, no history of primary risk factors, and non-alcoholic fatty liver disease), histologic grade (G1,G2,G3 or G4) and clinical stage (III, IV or I, II), with P < 0.05.
Quantitative real-time polymerase chain reaction validation
One normal human liver cell lines (L02) and three human HCC cell lines (HepG2, Hep3B, and Huh7) saved in our laboratory were grown in Dulbecco’s modified Eagle’s medium (GIBCO-BRL, USA) plus 10% heat-inactivated fetal bovine serum (FBS) (GIBCO, USA), 100 U/mL penicillin, and 100 µg/mL streptomycin. All cells were maintained in a humidified incubator with 5% CO2 atmosphere at 37 °C. Twelve paired human HCC tumor and adjacent normal tissues were collected from the Second Affiliated Hospital of Nanjing Medical University, of which ten patients were in T1 stage and two patients were in T2 stage. Ethical approval was obtained from the Ethics Committee and written informed consent was obtained from all patients. The specimens were collected during surgery and immediately frozen in liquid nitrogen. The total RNA from cell lines and tissues was extracted through the Trizol Reagent (Invitrogen, USA) and 1 μg RNA was used to synthesize cDNA using SuperScriptR III Reverse Transcriptase (Vazyme, China). Real-time PCR was further performed with SYBR Green PCR Master Mix (Invitrogen, USA) on Cobas Z480 System (Roche, Germany). In this study, lncRNA qRT-PCR Primer Sets ( a pair of qPCR primers for each set) specific for PVT1, SFTA1P, C17orf82, AC016773.1, AC073352.1 and AL512652.1 designed by RiboBio (China), and all reactions were carried out in triplicate and β-actin were used as internal control and relative gene expressions were analyzed by the 2−△△ct method.
Statistical analysis
All bioinformatics analysis and statistical tests were performed with R language. Pearson correlation analysis was used to analyze the correlation between lncRNAs and miRNAs. Data were analyzed using GraphPad Prism 7 software (GraphPad, USA).
Results
Identification of DElncRNA/DEmiRNA/DEmRNAs
1070 DElncRNAs, including 1013 (94.67%) upregulated and 57 (5.33%) downregulated DElncRNAs in tumors were identified using the “edgeR” package. 147 DEmiRNAs, including 119 (80.95%) upregulated and 28 (19.05%) downregulated DEmiRNAs in tumors were also identified as significantly differentially expressed. Moreover, we got 1993 DEmRNAs, including 1788 (89.71%) upregulated and 205 (10.27%) downregulated DEmRNAs in tumors. The expression patterns were displayed in Fig. 1.
Construction of the ceRNA network
As shown in Fig. 2, a total of 349 lncRNA-miRNA pairs were identified by miRcode database, including 18 miRNAs and 79 lncRNAs. Then, the target genes of 18 miRNAs which identified in the above steps were predicted by miRTarBase and TargetScan, respectively. We gained 115 common mRNAs from the intersection of these target mRNAs and DEmRNAs, and 192 miRNA-mRNA pairs includes 17 miRNAs and 115 mRNAs. To better understand the role of DElncRNAs in HCC, we further constructed a ceRNA network by combining 349 lncRNA-miRNA interactions with 192 miRNA-mRNA interactions, which included 79 lncRNAs, 18 miRNAs, and 115 mRNAs.
Functional and pathway enrichment analysis of DEmRNAs
To further explore the systematic characterization and biological functions of the DEmRNAs in the ceRNA network, functional annotation and pathway analysis were extracted by GO and KEGG. The functional enrichment analysis suggested that the target genes of these mRNAs may be involved in various pathways related to “regulation of transcription”, “RNA metabolic process”, “cell cycle process”(GO);and “p53 signaling pathway”, “Pathways in cancer”, “pancreatic cancer”, “prostate cancer”, “small cell lung cancer”, and other noncancer-related pathways such as “cell cycle” (KEGG) (Fig. 3).
Survival analysis for RNAs in ceRNA network
Survival analysis was performed for the RNAs in the ceRNA network. We performed Kaplan–Meier univariate analysis to predict overall survival (OS) in HCC patients. Due to the lack of follow-up information, 304 cases were included for lncRNA and mRNA survival analysis, and 306 cases were included for miRNA survival analysis. A total of 27 DElncRNAs, five DEmiRNAs and 30 DEmRNAs were found to be associated with prognosis (Table 1).
Correlation analysis of lncRNA and miRNA
Correlation analysis was conducted on each lncRNA and miRNA (which associated with prognosis) based on the analysis of survival analysis in the previous steps. Pearson correlation coefficient analysis was used to find negatively correlated lncRNA and miRNA pairs, with P < 0.05. Correlation analysis between lncRNA and miRNA was visualized using corrplot (Fig. 4). Bounded by the coefficient < − 0.3, ultimately, we obtained six lncRNAs and two miRNAs.
Clinical significance of prognostic six lncRNAs
To further explore the relationship between the six lncRNAs (Table 2) and clinical data of HCC patients, clinicopathological characteristics were divided into different groups (Table 3). As show in Table 3, SFTA1P was correlated with gender, risk factors and clinical stage; AC016773.1 was correlated with age, risk factors and histologic grade; AC073352.1 was correlated with histologic grade; AL512652.1 was correlated with histologic grade and clinical stage. These results revealed that these lncRNAs can be used for effective risk stratification in HCC. However, PVT1 and C17orf82 showed no relationship with these factors.
Validation of lncRNAs through qRT-PCR
In terms of the above analysis from TCGA, these six lncRNAs (PVT1, SFTA1P, C17orf82, AC016773.1, AC073352.1 and AL512652.1) involving ceRNA network were regarded as potential biomarkers linked with HCC patients. As indicated in Fig. 5, the results of qRT-PCR were consistent with our findings in tissues (Fig. 5). Additionally, SFTA1P was not detected in L02, but was expressed in three human HCC cell lines (Fig. 6).
Discussion
Accumulating evidence has shown that lncRNAs can regulate mRNAs via sponge miRNAs, through epigenetic regulation, transcription regulation, and post-transcription regulation, and participate in tumorigenesis [14,15,16,17]. Therefore, the function of lncRNAs can be explored systematically through the ceRNA network.
In this study, we extracted transcriptome data from TCGA and identified 1993 DEmRNAs, 147 DEmiRNAs and 1070 DElncRNAs between HCC and adjacent normal tissues. To further investigate the role of ncRNAs and mRNAs in cancer, we predicted target lncRNAs of DEmiRNAs based on miRcode database, and then predicted target mRNAs of DEmiRNAs based on miRTarBase and TargetScan databases. Finally, HCC ceRNA network was constructed on the basis of 192 miRNA-mRNA interactions and 349 lncRNA-miRNA interactions. Furthermore, pathway analysis showed that mRNAs were enriched predominantly in “pathways in cancer”, “regulation of transcription”, “RNA metabolic process” and “cell cycle process”, indicating that these mRNAs were implicated in tumorigenesis.
Up to now, prognostic features of ceRNA network in HCC remain largely unknown. In this study, six DElncRNAs (PVT1, SFTA1P, C17orf82, AC016773.1, AC073352.1 and AL512652.1), two DEmiRNAs (hsa-mir-214, hsa-mir-424), and seven DEmRNAs (CPNE7, GNAL, ASF1B, GLP2R, PRSS21, HOXA3, ITGA2) in our ceRNA network showed significant association with OS in HCC patients. Further analysis showed that SFTA1P was correlated with gender, risk factors and clinical stage; AC016773.1 was correlated with age, risk factors and histologic grade; AC073352.1 was correlated with histologic grade; and AL512652.1 was correlated with clinical stage and histologic grade. Therefore, these lncRNAs could be utilized for risk stratification in HCC. The results of qRT-PCR showed that PVT1, C17orf82, AC016773.1, AC073352.1 and AL512652.1 were upregulated, indicating their potential as HCC biomarkers. While SFTA1P could only be detected in HCC cell lines, this may be resulted from that the expression of SFTA1P in L02 is lower than the detection limit of qRT-PCR. We postulated that SFTA1P may be a powerful marker for the diagnosis of HCC.
The human PVT1 gene located on 8q24 has 9–12 exons with the length of 1957 base pairs [18]. As an oncogenic lncRNA, PVT1 is highly expressed in non-small-cell lung cancer [19], colon cancer [20], leukemia [21], and HCC [22]. The biogenesis of PVT1 is still unclear, but PVT1 is involved in cancer cell differentiation, proliferation, invasion, and drug resistance, and is associated with OS and tumor stage [23, 24]. For example, PVT1 could upregulate miR-214 by promoting the binding of enhancer of zeste homolog 2 (EZH2) to its promoter, leading to increased ovarian cancer cell proliferation and invasion [25]. In this study, we found the same trend of expression of PVT1, miRNA-214 and miRNA-424 in HCC, but the mechanism needs to be clarified.
SFTA1P is the pseudogene-derived lncRNA located on 10p14 with the length of 693 nts, and can suppress the migration and invasion of lung adenocarcinoma (LUAD) and gastric cancer cells.[26,27,28]. However, we found that SFTA1P was upregulated in HCC, and was correlated with gender, risk factors and clinical stage of HCC, consistent with previous report [29]. Due to different expression of SFTA1P in different tissue types, its mechanism of action remains elusive.
C17orf82 located on 17q23.2 has one exon with the length of 1529 bp. Previous study revealed that C17orf82 is upregulated in hepatitis B virus-associated HCC [30], but the biological function remains unclear. In our study, hsa-mir-214 and hsa-mir-424 were predicted to be the response elements to regulate the expression of CCNE1, CCNE2 and CDK1. Besides PVT1, SFTA1P and C17orf82, three upregulated DElncRNAs (AC016773.1, AC073352.1and AL512652.1) have never been reported in previous studies and their biological function remains unknown.
Nevertheless, some limitations of this study should be acknowledged. First, compared to HCC tumor tissues, the number of adjacent tissues is less due to various factors of TCGA data collection, which could cause bias of our results. Second, whether these lncRNAs and their interactions in ceRNA are specific to HCC has not been confirmed.
In summary, this study systematically analyzed possible interacting genes in HCC by exploring lncRNA-related ceRNA networks, and identified six lnRNAs which may be helpful for understanding the oncogenesis and prognosis and of HCC.
Availability of data and material
The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
Ozakyol A. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology). J Gastrointest Cancer. 2017;48(3):238–40.
Wang H, Wang AH, Gressner OA, Fang M, Gu X, Ji Q, Cheng SQ, Shen F, Gao CF. Association between HBV Pre-S mutations and the intracellular HBV DNAs in HBsAg-positive hepatocellular carcinoma in China. Clin Exp Med. 2015;15(4):483–91.
Fang S, Huang SF, Cao J, Wen YA, Zhang LP, Ren GS. Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression. Clin Exp Med. 2013;13(2):127–34.
Miao Y, Ajami NE, Huang TS, et al. Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function. Nat Commun. 2018;9(1):292.
Tan DSW, Chong FT, Leong HS, et al. Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma. Nat Med. 2017;23(10):1167–75.
Wang P, Xu J, Wang Y, Cao X. An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism. Science. 2017;358(6366):1051–5.
Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353–8.
Bossi L, Figueroa-Bossi N. Competing endogenous RNAs: a target-centric view of small RNA regulation in bacteria. Nat Rev Microbiol. 2016;14(12):775–84.
Karreth FA, Reschke M, Ruocco A, et al. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell. 2015;161(2):319–32.
Kumar MS, Armenteros-Monterroso E, East P, et al. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature. 2014;505(7482):212–7.
Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–83.
Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407.
Grelet S, Link LA, Howley B, et al. A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression. Nat Cell Biol. 2017;19(9):1105–15.
Bosia C, Sgro F, Conti L, et al. RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells. Genome Biol. 2017;18(1):37.
Wang F, Xie C, Zhao W, Deng Z, Yang H, Fang Q. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Clin Exp Med. 2017;17(1):33–43.
Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C. p53-dependent induction of PVT1 and miR-1204. J Biol Chem. 2012;287(4):2509–19.
Li X, Zhang Z, Jiang H, et al. Circular RNA circPVT1 promotes proliferation and invasion through sponging miR-125b and activating E2F2 signaling in non-small cell lung cancer. Cell Physiol Biochem. 2018;51(5):2324–40.
Zhang R, Li J, Yan X, et al. Long noncoding RNA plasmacytoma variant translocation 1 (PVT1) promotes colon cancer progression via endogenous sponging miR-26b. Med Sci Monit. 2018;24:8685–92.
El-Khazragy N, Elayat W, Matbouly S, et al. The prognostic significance of the long non-coding RNAs "CCAT1, PVT1" in t(8;21) associated Acute Myeloid Leukemia. Gene. 2019;707:172–7.
Yang L, Peng X, Jin H, Liu J. Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma. Gene. 2019;697:94–102.
Feng K, Liu Y, Xu LJ, Zhao LF, Jia CW, Xu MY. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. Biomed Pharmacother. 2018;104:686–98.
He F, Song Z, Chen H, et al. Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128. Oncogene. 2019;38(2):164–79.
Chen Y, Du H, Bao L, Liu W. LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214. Cancer Biol Med. 2018;15(3):238–50.
Zhang H, Xiong Y, Xia R, Wei C, Shi X, Nie F. The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma. Tumour Biol. 2017;39(2):1010428317691418.
Huang GQ, Ke ZP, Hu HB, Gu B. Co-expression network analysis of long noncoding RNAs (IncRNAs) and cancer genes revealsSFTA1P and CASC2abnormalities in lung squamous cell carcinoma. Cancer Biol Ther. 2017;18(2):115–22.
Ma H, Ma T, Chen M, Zou Z, Zhang Z. The pseudogene-derived long non-coding RNA SFTA1P suppresses cell proliferation, migration, and invasion in gastric cancer. Biosci Rep. 2018;38(2):BSR20171193.
Liao HT, Huang JW, Lan T, et al. Identification of The aberrantly Expressed LncRNAs in hepatocellular carcinoma: a bioinformatics analysis based on RNA-sequencing. Sci Rep. 2018;8(1):5395.
Mou Y, Wang D, Xing R, et al. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Cancer Biomark. 2018;23(1):95–106.
Acknowledgments
This study was supported by the Second Affiliated Hospital of Nanjing Medical University Medical Development and Support Fund, Jiangsu Provincial “333 project” Fund for High-level Talent Cultivation (No. BRA2018086), the Science and Technology Development Foundation of Nanjing Medical University of China (No. 2016NJMUZD034).
Author information
Authors and Affiliations
Contributions
YZ and CS designed the study. LQ and XC wrote the manuscript. LQ, XC, and YZ revised the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Ethics approval
This study was approved by the Medical Ethics Committee of the Secondary Affiliated Hospital of Nanjing Medical University (Acceptance No. 2019-KY-061).
Informed consent
Additional informed consent was obtained from all patients ahead of the experiments.
Consent to participate
Additional informed consent was obtained from all patients ahead of the experiments.
Consent for publication
All authors have approved the manuscript publication.
Code availability
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Qu, L., Cai, X., Xu, J. et al. Six long noncoding RNAs as potentially biomarkers involved in competitive endogenous RNA of hepatocellular carcinoma. Clin Exp Med 20, 437–447 (2020). https://doi.org/10.1007/s10238-020-00634-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-020-00634-3